---
configuration: 
  locale: en-US
  dynamo: mock

--- 
- test: NavigateCNAIntent_S 
- LaunchRequest
- NavigateCNAIntent:
  - request.session.attributes:
      MELVIN.STATE:
        study_abbreviation: "OV"
  - response.outputSpeech.ssml: "HCN2 has the greatest number of copy number alterations in Ovarian serous cystadenocarcinoma at 59.5 percent."
  - response.shouldEndSession: false
- AMAZON.CancelIntent: Goodbye!

--- 
- test: NavigateCNAIntent_G
- LaunchRequest
- NavigateCNAIntent:
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
  - response.outputSpeech.ssml: "In TP53 greatest number of copy number alterations are found in Sarcoma patients at 37.6 percent."
  - response.shouldEndSession: false
- AMAZON.CancelIntent: Goodbye!

--- 
- test: NavigateCNAIntent_GS
- LaunchRequest
- NavigateCNAIntent:
  - request.request.intent.slots:
      query:
        name: "query"
        value: "ovarian cancer"
        confirmationStatus: "NONE"
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "BRCA1"
  - response.outputSpeech.ssml: "In Ovarian serous cystadenocarcinoma patients, Braca one is amplified 4.5 percent and deleted 8 percent."
  - response.shouldEndSession: false
- AMAZON.CancelIntent: Goodbye!

--- 
- test: NavigateGainIntent_S 
- LaunchRequest
- NavigateGainIntent:
  - request.request.intent.slots:
      query:
        name: "query"
        value: "breast cancer"
        confirmationStatus: "NONE"
  - response.outputSpeech.ssml: "CCND1 has the greatest number of amplifications in Breast invasive carcinoma at 27.4 percent"
  - response.shouldEndSession: false
- AMAZON.CancelIntent: Goodbye!

--- 
- test: NavigateGainIntent_G
- LaunchRequest
- NavigateGainIntent:
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
  - response.outputSpeech.ssml: "In TP53 greatest number of amplifications are found in Ovarian serous cystadenocarcinoma patients at 9.4 percent."
  - response.shouldEndSession: false
- AMAZON.CancelIntent: Goodbye!

--- 
- test: NavigateGainIntent_GS
- LaunchRequest
- NavigateGainIntent:
  - request.request.intent.slots:
      query:
        name: "query"
        value: "breast cancer"
        confirmationStatus: "NONE"
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
  - response.outputSpeech.ssml: "In Breast invasive carcinoma patients, TP53 is amplified 1.5 percent."
  - response.shouldEndSession: false
- AMAZON.CancelIntent: Goodbye!


--- 
- test: NavigateLossIntent_S 
- LaunchRequest
- NavigateLossIntent:
  - request.request.intent.slots:
      query:
        name: "query"
        value: "breast cancer"
        confirmationStatus: "NONE"
  - response.outputSpeech.ssml: "KAZN has the greatest number of deletions in Breast invasive carcinoma at 16.9 percent."
  - response.shouldEndSession: false
- AMAZON.CancelIntent: Goodbye!

--- 
- test: NavigateLossIntent_G
- LaunchRequest
- NavigateLossIntent:
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
  - response.outputSpeech.ssml: "In TP53 greatest number of deletions are found in Sarcoma patients at 34.1 percent."
  - response.shouldEndSession: false
- AMAZON.CancelIntent: Goodbye!

--- 
- test: NavigateLossIntent_GS
- LaunchRequest
- NavigateLossIntent:
  - request.request.intent.slots:
      query:
        name: "query"
        value: "breast cancer"
        confirmationStatus: "NONE"
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
  - response.outputSpeech.ssml: "In Breast invasive carcinoma patients, TP53 is deleted 4.3 percent."
  - response.shouldEndSession: false
- AMAZON.CancelIntent: Goodbye!